Proteogenix
From Wikipedia, the free encyclopedia
 |
This article is an orphan, as no other articles link to it. (February 2009) |
Proteogenix is a corporation based in Portland, Oregon, United States, that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome, which combined cause 175,000 premature births each year in the United States alone.[1]
Proteogenix has gained negative publicity through their use of unsolicited commercial email (spam).[2]
References [edit]
- ^ "ProteoGenix News from The BioSpace Beat". Biospace.com. September 29, 2004.
- ^ . Mainsleaze.spambouncer.org. February 21, 2013 http://mainsleaze.spambouncer.org/?p=2943. Unknown parameter
|Title=ignored (|title=suggested) (help); Missing or empty|title=(help)>
